· Original article
Rett biomarker program at Niki featured in IRSF series
Niki’s Rett biomarker program features in an IRSF research series as its DiamiR subsidiary explores blood-based tools for tracking disease progression.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Read the original source and publication date in each article.
Results: 1,582 · Page 39 / 132
· Original article
Niki’s Rett biomarker program features in an IRSF research series as its DiamiR subsidiary explores blood-based tools for tracking disease progression.
· Original article
Aduro results for fiscal Q1 2027 show C$65.7 million in cash after equity financing, while a non-cash gain masks a wider adjusted EBITDA loss.
· Original article
NVIDIA's RTX Spark laptops launched October 16 from six PC makers, starting at $2,599, with up to 128GB of unified memory for local AI and creative work.
· Original article
Silicon Motion dividend rises to $2.30 per ADS, with four quarterly payments planned from November 2026 through August 2027, subject to board changes.
· Original article
Biomerica earnings show a $1.2 million fiscal Q1 loss and weaker margins, while September Medicare-related test orders rose from a small base.
· Original article
Toll Brothers plans to open Cypress Reserve in Clermont, Florida, for sales in early 2027, with lakefront homes priced from the mid-$800,000s.
· Original article
Turkish Airlines engines MoU covers more than 300 LEAP-1B purchases, broader fleet services and support for a planned maintenance facility in Turkey.
· Original article
Duos Technologies plans an October 20 presentation at the LD Micro Main Event in Los Angeles, with a webcast and meetings for institutional investors.
· Original article
BCB Bancorp earnings for the third quarter of 2026 are due before market open on October 29, followed by a management call at 8:45 a.m. Eastern.
· Original article
IBM shares gained on October 15 as Morgan Stanley raised its target to $238 but kept Equal Weight, with second-half cash generation still in focus.
· Original article
Ironwood CEO succession puts commercial chief Tammi Gaskins in charge on January 1, 2027, while retiring CEO Tom McCourt remains on the board.
· Original article
Organon announced interim six-year MIUDELLA trial results as the FDA reviews an application to extend the copper IUD’s approved duration of use.
Charts and market data by TradingView. Availability and delays vary by exchange.